An MFI tranche is not a sprint (as they say). It is a marathon. And the most recent marathon comes to a close at end of today. I am sad to report that if the picture on the left are the runners... we're the one crawling to the finish line.
Just 1 1/2 months ago, when I published my end of August report, this tranche was up 16.6%, leading the Russell 3000... which was 14.9%.
Fast forward to today.
| 11/15/2017 | Start | Current | Dividend | Pct Gain | R3K Gain |
| MSGN | $16.67 | $25.91 | $0.00 | 55.4% | 7.2% |
| CELG | $100.60 | $70.24 | $0.00 | -30.2% | 7.2% |
| EVC | $5.78 | $3.40 | $0.20 | -37.7% | 7.2% |
| SIMO | $46.88 | $35.22 | $1.20 | -22.3% | 7.2% |
| VIAB | $24.41 | $32.05 | $0.80 | 34.6% | 7.2% |
| Totals | 0.0% | 7.2% |
Shocking... right? Looks like I'll have two stinkers. Here is how the individual stocks have done since end of August.
| Stock | August | Current | Dividend | Change |
| MSGN | 25.08 | 25.91 | - | 3.3% |
| CELG | 94.24 | 70.24 | - | -25.5% |
| EVC | 5.13 | 3.40 | 0.05 | -32.7% |
| SIMO | 58.95 | 35.22 | 0.30 | -39.7% |
| VIAB | 29.93 | 32.05 | 0.20 | 7.8% |
Pardon me while I puke! Sad to report, this is kind of my overall story since the end of August. Although it has been more on my non-MFI side than MFI (actually MFI Formula is doing great).
I will be buying 5 new names tomorrow. I'll need to look at EVC to see if their sell-off was warranted. I suspect I'll definitely sell all the other names. Man, this sucks.
Posts
No comments:
Post a Comment